Candidate Compounds Covid19

Aus coViki
Wechseln zu: Navigation, Suche

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

current items will be put into the subsections.






  • GET 2020. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here? Extract
  • GET 2020. How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19. Extract
  • GET 2020. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Extract
  • GET 2020. Controle do Intervalo QT para Prevencao de Torsades de Pointes Durante uso de Hidroxicloroquina e/ou Azitromicina em Pacientes com COVID 19. Extract
  • GET 2020. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms. Extract
  • GET 2020. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks. Extract
  • GET 2020. Is hydroxychloroquine beneficial for COVID-19 patients? Extract
  • GET 2020. Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era. Extract
  • GET 2020. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. Extract
  • GET 2020. Effect of favipiravir and an anti-inflammatory strategy for COVID-19. Extract
  • GET 2020. Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19. Extract
  • GET 2020. Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series. Extract
  • GET 2020. A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2. Extract
  • GET 2020. Vitamin D deficiency in patients with diabetes and COVID- 19 infection. Extract
  • GET 2020. Application of Artificial Intelligence in COVID-19 drug repurposing. Extract
  • GET 2020. Concentration-dependent mortality of chloroquine in overdose. Extract
  • GET 2020. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines. Extract
  • GET 2020. Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry. Extract
  • GET 2020. Potential of regulatory T cell-based therapies in the management of severe COVID-19. Extract
  • GET 2020. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Extract
  • GET 2020. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Extract
  • GET 2020. Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2. Extract
  • GET 2020. Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk. Extract
  • GET 2020. INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc). Extract
  • GET 2020. Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management. Extract
  • GET 2020. Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update. Extract
  • GET 2020. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Extract
  • GET 2020. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Extract
  • GET 2020. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab. Extract
  • GET 2020. An update on antiviral antibody-based biopharmaceuticals. Extract
  • GET 2020. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19. Extract
  • GET 2020. COVID-19 Treatment: Close to a Cure? - A Rapid Review of Pharmacotherapies for the Novel Coronavirus. Extract
  • GET 2020. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab. Extract
  • GET 2020. CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection. Extract
  • GET 2020. Passive immunization: Paradoxical and traditional method for new pandemic challenge COVID-19. Extract
  • GET 2020. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not. Extract
  • GET 2020. Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections. Extract
  • GET 2020. Poly(ADP-ribose) Polymerase Inhibition in Acute Lung Injury: A Re-emerging Concept. Extract
  • GET 2020. COVID-19 Clinical Trials: Unravelling a Methodological Gordian Knot. Extract
  • GET 2020. Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports. Extract
  • GET 2020. Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study. Extract
  • GET 2020. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Extract
  • GET 2020. COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study. Extract
  • GET 2020. Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al. Extract
  • GET 2020. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Extract
  • GET 2020. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Extract
  • GET 2020. Clinical trials of repurposed antivirals for SARS-CoV-2. Extract
  • GET 2020. Trainee Led Collaboratives, Clinical Trials And New Opportunities In The Covid-19 Era. Extract
  • GET 2020. Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus. Extract
  • GET 2020. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19. Extract
  • GET 2020. Urgent call for greater multilateralism and coordination of covid-19 trials. Extract
  • GET 2020. Covid-19: research methods must be flexible in a crisis. Extract
  • GET 2020. Dexamethasone in the management of covid -19. Extract
  • GET 2020. Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds. Extract
  • GET 2020. COVID-19 clinical trials: see it big and keep it simple. Extract
  • GET 2020. Serious adverse events with tocilizumab: pharmacovigilance as an aid to prioritize monitoring in COVID-19. Extract
  • GET 2020. Potential role of IL-17 blocking agents in the treatment of severe COVID-19? Extract
  • GET 2020. Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2. Extract
  • GET 2020. COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges. Extract
  • GET 2020. Proteinase-activated receptor 1 (PAR1): A target for repurposing in the treatment of COVID-19? Extract
  • GET 2020. Current Therapies Under Investigation for COVID-19. Extract
  • GET 2020. Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations. Extract
  • GET 2020. Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection. Extract
  • GET 2020. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity. Extract
  • GET 2020. Immune checkpoint inhibition in the era of COVID-19. Extract
  • GET 2020. Proposing minimum requirements for announcing clinical trial results during the COVID-19 pandemic. Extract
  • GET 2020. Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development. Extract
  • GET 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Extract
  • GET 2020. Smoking in critically ill patients with COVID-19: the Australian experience. Extract
  • GET 2020. Analytical Methods on Determination in Pharmaceuticals and Biological Materials of Chloroquine as Available for the Treatment of COVID-19. Extract
  • GET 2020. Effect of the Phytochemical Agents Against the SARS-CoV and Selected Some of them for Application to COVID-19: A Mini-Review. Extract
  • GET 2020. Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19). Extract
  • GET 2020. The role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases. Extract
  • GET 2020. Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation. Extract
  • GET 2020. Therapeutic targets and computational approaches on drug development for COVID-19. Extract
  • GET 2020. Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. Extract
  • GET 2020. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Extract
  • GET 2020. Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review. Extract
  • GET 2020. Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges. Extract
  • GET 2020. BET 2: Hydroxychloroquine in the treatment of COVID-19. Extract
  • GET 2020. BET 1: Lopinavir-ritonavir and COVID-19. Extract
  • GET 2020. Bacillus Calmette-Guerin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study. Extract
  • GET 2020. SGLT2 inhibition and COVID-19: The road not taken. Extract
  • GET 2020. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? Extract
  • GET 2020. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19. Extract
  • GET 2020. Predictor of poor prognosis of COVID-19 patients----liver injury. Extract
  • GET 2020. Liver injury in severe COVID-19 infection: current insights and challenges. Extract
  • GET 2020. Balancing infection control and frailty prevention during and after the COVID-19 pandemic: Introduction of the NCGG Home Exercise Program for Older People 2020. Extract
  • GET 2020. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19? Extract
  • GET 2020. Thinking more about therapy with convalescent plasma for COVID-19 patients. Extract
  • GET 2020. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Extract
  • GET 2020. Effect of recombinant human granulocyte colony-stimulating factor on lymphocyte subsets in patients with COVID-19. Extract
  • GET 2020. Suggestions for Combatting COVID-19 by Natural Means in the Absence of Standard Medical Regimens. Extract
  • GET 2020. Combating COVID-19 and Building Immune Resilience: A Potential Role for Magnesium Nutrition? Extract
  • GET 2020. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Extract
  • GET 2020. Potential of NO donor furoxan as SARS-CoV-2 main protease (M(pro)) inhibitors: in silico analysis. Extract
  • GET 2020. Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: in-silico drug discovery. Extract
  • GET 2020. Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study. Extract
  • GET 2020. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study. Extract
  • GET 2020. Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations. Extract
  • GET 2020. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach. Extract
  • GET 2020. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. Extract
  • GET 2020. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach. Extract
  • GET 2020. Convalescent plasma therapy in patients with COVID-19. Extract
  • GET 2020. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making. Extract
  • GET 2020. Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management. Extract
  • GET 2020. Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. Extract
  • GET 2020. Erythropoietin Induced Hemoglobin Sub-Unit Beta may Stimulate Innate Immune RNA Virus Pattern Recognition, Suppress Reactive Oxygen Species, Reduce ACE2 Viral Doorway Opening and Neutrophil Extracellular Traps against Covid-19. Extract
  • GET 2020. A retrospective review of memantine use and COVID-19-associated mortality from a national database. Extract
  • GET 2020. RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target. Extract
  • GET 2020. Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study. Extract
  • GET 2020. Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Extract
  • GET 2020. Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study. Extract
  • GET 2020. A pharmacological perspective of Chloroquine in SARS-CoV-2 infection. Extract
  • GET 2020. Case reports study of the first five patients COVID-19 treated with remdesivir in France. Extract
  • GET 2020. Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy. Extract
  • GET 2020. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Extract
  • GET 2020. An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction. Extract
  • GET 2020. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review. Extract
  • GET 2020. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products. Extract
  • GET 2020. Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic. Extract
  • GET 2020. Nucleic Acid Approaches to Antibody-based Therapeutics for COVID-19: A Perspective. Extract
  • GET 2020. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. Extract
  • GET 2020. Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives. Extract
  • GET 2020. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening. Extract
  • GET 2020. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? (). Extract
  • GET 2020. Azithromycin and SARS-CoV-2 infection: where we are now and where we are going. Extract
  • GET 2020. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy. Extract
  • GET 2020. On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19. Extract
  • GET 2020. Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles. Extract
  • GET 2020. Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role? Extract
  • GET 2020. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates. Extract
  • GET 2020. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. Extract
  • GET 2020. Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19). Extract
  • GET 2020. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19. Extract
  • GET 2020. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy. Extract
  • GET 2020. Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro)). Extract
  • GET 2020. Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review. Extract
  • GET 2020. Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine. Extract
  • GET 2020. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Extract
  • GET 2020. The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine. Extract
  • GET 2020. COVID-19 and vitamin D deficiency, a fatal combination? Extract
  • GET 2020. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. Extract
  • GET 2020. Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome? Extract
  • GET 2020. Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis. Extract
  • GET 2020. Ultraviolet-based Biophotonic Technologies and COVID-19. Extract
  • GET 2020. Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library. Extract
  • GET 2020. Letter to the editor regarding "Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable". Extract
  • GET 2020. Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)? Extract
  • GET 2020. A candidate multi-epitope vaccine against SARS-CoV-2. Extract
  • GET 2020. Alternative management of Covid-19 infection. Extract
  • GET 2020. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia. Extract
  • GET 2020. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials. Extract
  • GET 2020. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". Extract
  • GET 2020. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review. Extract
  • GET 2020. Prospects and Challenges in the Development of Universal Influenza Vaccines. Extract
  • GET 2020. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Extract
  • GET 2020. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Extract
  • GET 2020. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review. Extract
  • GET 2020. Low Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care. Extract
  • GET 2020. Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19? Extract
  • GET 2020. The Development of COVID-19 Vaccines: Safeguards Needed. Extract
  • GET 2020. Developing a SARS-CoV-2 Vaccine at Warp Speed. Extract
  • GET 2020. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19. Extract
  • GET 2020. Editorial - Nutritional Status Affects COVID-19 Patient Outcomes. Extract
  • GET 2020. Evaluation of Nutritional Risk and its Association With Mortality Risk in Severe and Critically Ill COVID-19 Patients. Extract
  • GET 2020. Low dose radiation as a treatment for COVID-19 pneumonia: a threat or real opportunity? Extract
  • GET 2020. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. Extract
  • GET 2020. Safety of Plasma Infusions in Parkinson's Disease. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug. Extract
  • GET 2020. COVID-19 platform trial delivers. Extract
  • GET 2020. Going back in time for an antibody to fight COVID-19. Extract
  • GET 2020. Golden Anniversary of the Nicotinic Receptor. Extract
  • GET 2020. Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Extract
  • GET 2020. Is povidone-iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Extract
  • GET 2020. Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19. Extract
  • GET 2020. COVID-19: Phylogenetic approaches may help in finding resources for natural cure. Extract
  • GET 2020. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Extract
  • GET 2020. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. Extract
  • GET 2020. Using heat to kill SARS-CoV-2. Extract
  • GET 2020. Can interferons stop COVID-19 before it takes hold? Extract
  • GET 2020. Potential Immunotherapeutic Targets For Hypoxia Due to COVI-FLU. Extract
  • GET 2020. COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates. Extract
  • GET 2020. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation. Extract
  • GET 2020. SARS-CoV2 and immunosuppression: a double-edged sword. Extract
  • GET 2020. Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib. Extract
  • GET 2020. Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs. Extract
  • GET 2020. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro). Extract
  • GET 2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Extract
  • GET 2020. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection. Extract
  • GET 2020. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Extract
  • GET 2020. Gut microbiota and Covid-19- possible link and implications. Extract
  • GET 2020. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2. Extract
  • GET 2020. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Extract
  • GET 2020. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Extract
  • GET 2020. Micronutrient status of COVID-19 patients: a critical consideration. Extract
  • GET 2020. Rationale for targeting Complement in COVID-19. Extract
  • GET 2020. Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition. Extract
  • GET 2020. A role for selenium-dependent GPX1 in SARS-CoV-2 virulence. Extract
  • GET 2020. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2. Extract
  • GET 2020. Statins and other drugs: Facing COVID-19 as a vascular disease. Extract
  • GET 2020. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Extract
  • GET 2020. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Extract
  • GET 2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis. Extract
  • GET 2020. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight? Extract
  • GET 2020. The cholinergic anti-inflammatory pathway alleviates acute lung injury. Extract
  • GET 2020. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD. Extract
  • GET 2020. Gut-lung axis and dysbiosis in COVID-19. Extract
  • GET 2020. Door to the cell for COVID-19 opened, leading way to therapies. Extract
  • GET 2020. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series. Extract
  • GET 2020. Targeting the entry step of SARS-CoV-2: a promising therapeutic approach. Extract
  • GET 2020. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19. Extract
  • GET 2020. ACE2, Much More Than Just a Receptor for SARS-COV-2. Extract
  • GET 2020. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Extract
GET 2020. Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis. Extract
  • GET 2020. Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis. Extract
  • GET 2020. Critical Differences Between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV. Extract
  • GET 2020. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach. Extract
  • GET 2020. Identification of common deletions in the spike protein of SARS-CoV-2. Extract
  • GET 2020. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface. Extract
  • GET 2020. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Extract
  • GET 2020. Supplements for COVID-19: A modifiable environmental risk. Extract


  • GET 2020. Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment. Extract
  • GET 2020. Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment. Extract
  • GET 2020. Hard Nanomaterials in Time of Viral Pandemics. Extract
  • GET 2020. Cannabis terapeutico y COVID-19: entre el oportunismo y la infoxicacion. Extract
  • GET 2020. Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae. Extract
  • GET 2020. Associations between hypovitaminosis D and COVID-19: a narrative review. Extract
  • GET 2020. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic? Extract
  • GET 2020. Inhibiting Fusion with Cellular Membrane System: Therapeutic Options to Prevent Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Extract
  • GET 2020. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? Extract
  • GET 2020. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial. Extract
  • GET 2020. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Extract
  • GET 2020. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19. Extract
  • GET 2020. Does androgen deprivation therapy protect against severe complications from COVID-19? Extract
  • GET 2020. Tongue diagnosis and treatment in traditional Chinese medicine for severe COVID-19: a case report. Extract
  • GET 2020. Safety, pharmacokinetics, and activity of high-dose ivermectin and chloroquine against the liver-stage of Plasmodium cynomolgi infection in Rhesus Macaques. Extract
  • GET 2020. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Extract
  • GET 2020. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Extract
  • GET 2020. Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection. Extract
  • GET 2020. Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro. Extract
  • GET 2020. Response to: Amantadine Treatment for People with COVID-19. Extract
  • GET 2020. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand. Extract
  • GET 2020. Approaching Coronavirus Disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Extract
  • GET 2020. PARP-inhibitors in a non-oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open. Extract
  • GET 2020. Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target. Extract
  • GET 2020. Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol. Extract
  • GET 2020. Purinergic signaling in infectious diseases of the central nervous system. Extract
  • GET 2020. Regional differences in use of immune-modulating catechins should be investigated regarding COVID-19. Extract
  • GET 2020. Reply to the Letter to the Editor: Regional differences in dietary use of immune-modulating catechins should be investigated regarding COVID-19. Extract
  • GET 2020. Ivermectin: potential candidate for the treatment of Covid 19. Extract
  • GET 2020. The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients. Extract
  • GET 2020. Ion channel inhibition against COVID-19: A novel target for clinical investigation. Extract
  • GET 2020. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Extract
  • GET 2020. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro. Extract
  • GET 2020. Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients. Extract
  • GET 2020. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice. Extract
  • GET 2020. Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19. Extract
  • GET 2020. The minimal effect of zinc on the survival of hospitalized patients with Covid-19: an observational study. Extract
  • GET 2020. Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial. Extract
  • GET 2020. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking. Extract
  • GET 2020. Current strategies against COVID-19. Extract
  • GET 2020. Pandemia de COVID19: implicacoes para (in)seguranca alimentar e nutricional. Extract
  • GET 2020. Tocilizumab, Adipokines and Severe Complications of COVID-19. Extract
  • GET 2020. Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19. Extract
  • GET 2020. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine. Extract
  • GET 2020. mTORC inhibitor Sirolimus deprograms monocytes in "cytokine storm" in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome. Extract
  • GET 2020. Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'. Extract
  • GET 2020. COVID-19, hydroxychloroquine and the eighth alternative. Extract
  • GET 2020. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Extract
  • GET 2020. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Extract
  • GET 2020. COVID-19 and hydroxychloroquine: Let the available data speak for themselves. Extract
  • GET 2020. COVID-19 Therapeutics: Making Sense of It All. Extract
  • GET 2020. Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection. Extract
  • GET 2020. Old drugs for a new virus: repurposed approaches for combating COVID-19. Extract
  • GET 2020. Montelukast in children with allergic rhinitis amid COVID-19 pandemic. Extract
  • GET 2020. The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review. Extract
  • GET 2020. The Regulation of COVID-19 "Challenge" Studies. Extract
  • GET 2020. Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C. Extract
  • GET 2020. First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection. Extract
  • GET 2020. Nutrition Support in the ICU-A Refresher in the Era of COVID-19. Extract
  • GET 2020. Inhaled Corticosteroids and COVID-19. Extract
  • GET 2020. Reply to: Inhaled Corticosteroids and COVID-19. Extract
  • GET 2020. More Studies are Needed on the Link between Metformin and Decreased Mortality in Diabetic COVID-19 Patients. Extract
  • GET 2020. Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials. Extract
  • GET 2020. Current status of COVID-19 (pre)clinical vaccine development. Extract
  • GET 2020. Repurposing Existing Drugs for the Treatment of COVID-19. Extract
  • GET 2020. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement. Extract
  • GET 2020. Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trial. Extract
  • GET 2020. Potential role of Bacillus Calmette-Guerin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Extract
  • GET 2020. Chloroquine in fighting COVID-19: good, bad, or both? Extract
  • GET 2020. COVID-19 Docking Server: A meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19. Extract
  • GET 2020. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M(pro)) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation. Extract
  • GET 2020. Intensive immunosuppression reduces deaths in covid-19-associated cytokine storm syndrome, study finds. Extract
  • GET 2020. Are we responsible for the racial inequalities of covid-19? Extract
  • GET 2020. Covid-19: Experts criticise claim that remdesivir cuts death rates. Extract
  • GET 2020. Model-Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID-19. Extract
  • GET 2020. ABNORMAL LABORATORY FINDINGS AND PLASMA CONCENTRATION MONITORING OF LOPINAVIR AND RITONAVIR IN COVID-19. Extract
  • GET 2020. Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin. Extract
  • GET 2020. Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials. Extract
  • GET 2020. Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection. Extract
  • GET 2020. COVID-19 and Misinformation: How an Infodemic Fueled the prominence of Vitamin D. Extract
  • GET 2020. THE RATIONALE FOR A MULTI-STEP THERAPEUTIC APPROACH BASED ON ANTIVIRALS, DRUGS, AND NUTRIENTS WITH IMMUNOMODULATORY ACTIVITY IN PATIENTS WITH CORONAVIRUS-SARS2-INDUCED DISEASE OF DIFFERENT SEVERITY. Extract
  • GET 2020. Non-steroidal anti-inflammatory drugs, prostaglandins and COVID-19. Extract
  • GET 2020. Safety perspectives on presently considered drugs for the treatment of COVID-19. Extract
  • GET 2020. Targeting zinc metalloenzymes in COVID-19. Extract
  • GET 2020. Clozapine treatment and risk of COVID-19. Extract
  • GET 2020. Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses. Extract
  • GET 2020. Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2. Extract
  • GET 2020. Targeting SARS-CoV-2 RBD interface: a supervised computational data-driven approach to identify potential modulators. Extract
  • GET 2020. IL-6 Blockade and QTc Prolongation in COVID-19. Extract
  • GET 2020. In response to: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity. Extract
  • GET 2020. Micronutrients as immunomodulatory tools for COVID-19 management. Extract
  • GET 2020. Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care. Extract
  • GET 2020. Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial. Extract
  • GET 2020. Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors. Extract
  • GET 2020. Treatment of COVID-19 - Evidence-Based or Personalized Medicine? Extract
  • GET 2020. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Extract
  • GET 2020. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection. Extract
  • GET 2020. Endpoints for randomized controlled clinical trials for COVID-19 treatments. Extract
  • GET 2020. Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic. Extract
  • GET 2020. Clinical trials in the time of a pandemic. Extract
  • GET 2020. Editorial: Clinical trial design in the era of COVID-19. Extract
  • GET 2020. Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population. Extract
  • GET 2020. Role for antimalarials in the management of COVID-19. Extract
  • GET 2020. Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV). Extract
  • GET 2020. Insights in chloroquine action: perspectives and implications in Malaria and COVID-19. Extract
  • GET 2020. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless? Extract
  • GET 2020. Dexamethasone for COVID-19: preliminary findings. Extract
  • GET 2020. High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection. Extract
  • GET 2020. Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues. Extract
  • GET 2020. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2. Extract
  • GET 2020. A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients. Extract
  • GET 2020. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications. Extract
  • GET 2020. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach. Extract
  • GET 2020. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Extract
  • GET 2020. Chinese herbal experience for the 2019 novel coronavirus. Extract
  • GET 2020. Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials. Extract
  • GET 2020. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study. Extract
  • GET 2020. Blocking IL-1 to prevent respiratory failure in COVID-19. Extract
  • GET 2020. Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series. Extract
  • GET 2020. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation. Extract
  • GET 2020. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia. Extract
  • GET 2020. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis. Extract
  • GET 2020. Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases. Extract
  • GET 2020. Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease? Extract
  • GET 2020. Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic? Extract
  • GET 2020. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19). Extract
  • GET 2020. Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines. Extract
  • GET 2020. Pharmaco-Immunomodulatory Therapy in COVID-19. Extract
  • GET 2020. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments. Extract
  • GET 2020. Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia. Extract
  • GET 2020. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis. Extract
  • GET 2020. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies. Extract
  • GET 2020. Waste in COVID-19 clinical trials conducted in western Europe. Extract
  • GET 2020. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal. Extract
  • GET 2020. Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses. Extract
  • GET 2020. A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection. Extract
  • GET 2020. Advances in the possible treatment of COVID-19: A review. Extract
  • GET 2020. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2. Extract
  • GET 2020. An overview of safety assessment of the medicines currently used in the treatment of COVID-19 disease. Extract
  • GET 2020. Selenium - associated gene signatures within the SARS-CoV-2 - host genomic interaction interface. Extract
  • GET 2020. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Extract
  • GET 2020. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine. Extract
  • GET 2020. GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. Extract
  • GET 2020. Severe COVID-19: NLRP3 Inflammasome Dysregulated. Extract
  • GET 2020. Traditional Chinese medicine for combating COVID-19. Extract
  • GET 2020. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China. Extract
  • GET 2020. Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly. Extract
  • GET 2020. Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol. Extract
  • GET 2020. Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection. Extract
  • GET 2020. Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives. Extract
  • GET 2020. Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics. Extract
  • GET 2020. N-acetylcysteine as a potential treatment for novel coronavirus disease 2019. Extract
  • GET 2020. Association between famotidine use and COVID-19 severity in Hong Kong: a territory-wide study. Extract
  • GET 2020. Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2. Extract
  • GET 2020. Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial. Extract
  • GET 2020. Complement C5 inhibition in patients with COVID-19 - a promising target? Extract
  • GET 2020. Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. Extract
  • GET 2020. Ribavirin Therapy For Severe COVID-19: A Retrospective Cohort Study. Extract
  • GET 2020. Tocilizumab for severe COVID-19: a systematic review and meta-analysis. Extract
  • GET 2020. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19? Extract
  • GET 2020. The Lord of the NanoRings: cyclodextrins and the battle against SARS-CoV-2. Extract
  • GET 2020. Radiation Therapy as a Treatment for COVID-19? Extract
  • GET 2020. Low-dose Whole-lung Irradiation for COVID-19 Pneumonia: Short Course Results. Extract
  • GET 2020. Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. Extract
  • GET 2020. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-beta and IFN inducer. Extract
  • GET 2020. The combination of artificial intelligence and systems biology for intelligent vaccine design. Extract
  • GET 2020. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Extract
  • GET 2020. Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study. Extract
  • GET 2020. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Extract
  • GET 2020. The Use of IV vitamin C for patients with COVID-19: a single center observational study. Extract
  • GET 2020. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. Extract
  • GET 2020. Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin. Extract
  • GET 2020. Drug interactions with potential antivirals used for COVID-19 in older persons. Extract
  • GET 2020. Designing Pull Funding For A COVID-19 Vaccine. Extract
  • GET 2020. A Social and Behavioral Research Agenda to Facilitate COVID-19 Vaccine Uptake in the United States. Extract
  • GET 2020. Promise and challenges in the development of COVID-19 vaccines. Extract
  • GET 2020. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Extract
  • GET 2020. COVID-19 - Important considerations for developing and using a vaccine. Extract
  • GET 2020. An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein. Extract
  • GET 2020. MMR Vaccine and Covid-19: A Myth or a Low Risk-High Reward Preventive Measure? Extract
  • GET 2020. Chloroquine as chemoprophylaxis for COVID-19: Will this work? Extract
  • GET 2020. Re: Low-dose radiation therapy for COVID-19 pneumonia: is there any supportive evidence? Extract
  • GET 2020. COVID-19 and Vitamin D deficiency; the two pandemics. Are they correlated? Extract
  • GET 2020. COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors. Extract
  • GET 2020. Chinese Herbal Medicines During the Covid-19 Pandemic: A Role for Observational Studies. Extract
  • GET 2020. Can Vitamin D and L-Cysteine Co-Supplementation Reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans? Extract
  • GET 2020. Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. Extract
  • GET 2020. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies. Extract
  • GET 2020. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis. Extract
  • GET 2020. Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2. Extract
  • GET 2020. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. Extract
  • GET 2020. Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2. Extract
  • GET 2020. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Extract
  • GET 2020. In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M(pro)) from flavonoid based phytochemical constituents of Calendula officinalis. Extract
  • GET 2020. Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors. Extract
  • GET 2020. Dual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads. Extract
  • GET 2020. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. Extract
  • GET 2020. Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19. Extract
  • GET 2020. Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study. Extract
  • GET 2020. Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment. Extract
  • GET 2020. Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis. Extract
  • GET 2020. Cyanobacterial metabolites as promising drug leads against the M(pro) and PL(pro) of SARS-CoV-2: an in silico analysis. Extract
  • GET 2020. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. Extract
  • GET 2020. Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19. Extract
  • GET 2020. Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL(pro)). Extract
  • GET 2020. The latitude hypothesis, vitamin D, and SARS-Co-V2. Extract
  • GET 2020. Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study. Extract
  • GET 2020. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. Extract
  • GET 2020. Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches. Extract
  • GET 2020. Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies. Extract
  • GET 2020. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease. Extract
  • GET 2020. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1). Extract
  • GET 2020. Corticosteroids-induced osteonecrosis in COVID-19: a call for caution. Extract
  • GET 2020. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality. Extract
  • GET 2020. Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia. Extract
  • GET 2020. Stem cell therapies for COVID-19: Strategy and application. Extract
  • GET 2020. Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease. Extract
  • GET 2020. SARS-CoV-2 Main Protease: A Molecular Dynamics Study. Extract
  • GET 2020. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists. Extract
  • GET 2020. Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety. Extract
  • GET 2020. Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro. Extract
  • GET 2020. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections. Extract
  • GET 2020. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy. Extract
  • GET 2020. Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19. Extract
  • GET 2020. Vitamin D and COVID-19. Extract
  • GET 2020. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation. Extract
  • GET 2020. Obesity, COVID-19 and immunotherapy: the complex relationship! Extract
  • GET 2020. Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients. Extract
  • GET 2020. That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19. Extract
  • GET 2020. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus. Extract
  • GET 2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review. Extract
  • GET 2020. Chloroquine and Hydroxychloroquine in Coronavirus Disease 2019 (COVID-19). Facts, Fiction & the Hype. A Critical Appraisal. Extract
  • GET 2020. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? Extract
  • GET 2020. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949. Extract
  • GET 2020. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor. Extract
  • GET 2020. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach. Extract
  • GET 2020. Self-Amplifying RNA Viruses as RNA Vaccines. Extract
  • GET 2020. Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy. Extract
  • GET 2020. A consensus guideline of herbal medicine for coronavirus disease 2019. Extract
  • GET 2020. Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines. Extract
  • GET 2020. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. Extract
  • GET 2020. Retrospective Analysis of Dermatological Adverse Events Associated with Hydroxychloroquine Reported to the United States Food and Drug Administration. Extract
  • GET 2020. Plasma Therapies and Parabiosis in the COVID-19 Era. Extract
  • GET 2020. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. Extract
  • GET 2020. Blood Targets of Adjuvant Drugs Against COVID19. Extract
  • GET 2020. The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients. Extract
  • GET 2020. Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! Extract
  • GET 2020. Bioactivity Profile Similarities to Expand the Repertoire of COVID-19 Drugs. Extract
  • GET 2020. First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA. Extract
  • GET 2020. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19. Extract
  • GET 2020. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome. Extract
  • GET 2020. Could Bordetella pertussis vaccine protect against coronavirus COVID-19? Extract
  • GET 2020. Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development. Extract
  • GET 2020. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. Extract
  • GET 2020. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients. Extract
  • GET 2020. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin. Extract
  • GET 2020. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines. Extract
  • GET 2020. Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation. Extract
  • GET 2020. Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists. Extract
  • GET 2020. Withaferin A: a potential therapeutic agent against COVID-19 infection. Extract
  • GET 2020. Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19? Extract
  • GET 2020. Michael Acceptors Tuned by the Pivotal Aromaticity of Histidine to Block COVID-19 Activity. Extract
  • GET 2020. SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3. Extract
  • GET 2020. Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir. Extract
  • GET 2020. Reacciones adversas a farmacos utilizados en el tratamiento especifico de la infeccion por SARS-CoV-2. Extract
  • GET 2020. Commentary. Eliminating Vitamin D Deficiency During the COVID-19 Pandemic: A Call to Action. Extract
  • GET 2020. Blood nitrate and nitrite modulating nitric oxide bioavailability: potential therapeutic functions in COVID-19. Extract
  • GET 2020. Selenium Deficiency Is Associated with Mortality Risk from COVID-19. Extract
  • GET 2020. Polymorphism and Selection Pressure of SARS-CoV-2 Vaccine and Diagnostic Antigens: Implications for Immune Evasion and Serologic Diagnostic Performance. Extract
  • GET 2020. Two Examples of RNA Aptamers with Antiviral Activity. Are Aptamers the Wished Antiviral Drugs? Extract
  • GET 2020. Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review. Extract
  • GET 2020. Replica: Ivermectina en COVID-19. inverted question markArgumentum ad ignorantiam? Extract
  • GET 2020. Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates. Extract
  • GET 2020. The link between Vitamin D and Covid-19: distinguishing facts from fiction. Extract
  • GET 2020. SARS-CoV-2 in the first trimester of pregnancy: potential interference in placentation. Extract
  • GET 2020. Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS? Extract
  • GET 2020. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. Extract
  • GET 2020. Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association. Extract
  • GET 2020. SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen. Extract
  • GET 2020. SARS-CoV-2 replicating in non-primate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals. Extract
  • GET 2020. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study. Extract
  • GET 2020. Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Extract
  • GET 2020. Management of patients with generalised myasthenia gravis and COVID-19: four case reports. Extract
  • GET 2020. Oncology-inspired treatment options for COVID-19. Extract
  • GET 2020. Vitamin D and COVID-19: Lessons from Spaceflight Analogs. Extract
  • GET 2020. Benzothiazoles as potential antiviral agents. Extract
  • GET 2020. Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept. Extract
  • GET 2020. Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. Extract
  • GET 2020. Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: Three case reports. Extract
  • GET 2020. Pooling Data From Individual Clinical Trials in the COVID-19 Era. Extract
  • GET 2020. COVID-19 Antibody Trials Have Begun. Extract
  • GET 2020. Setting Expectations for Clinical Research During the COVID-19 Pandemic. Extract
  • GET 2020. [Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)]. Extract
  • GET 2020. Encouraging results from phase 1/2 COVID-19 vaccine trials. Extract
  • GET 2020. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Extract
  • GET 2020. Tackling the cytokine storm in COVID-19, challenges and hopes. Extract
  • GET 2020. In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV. Extract
  • GET 2020. Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection. Extract
  • GET 2020. Lopinavir-ritonavir para COVID-19: una revision sistematica viva. Extract
  • GET 2020. A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2. Extract
  • GET 2020. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data. Extract
  • GET 2020. COVID-19 in MuSK Myasthenia Gravis: A Case Report. Extract
  • GET 2020. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. Extract
  • GET 2020. Audio Interview: Dexamethasone and Covid-19. Extract
  • GET 2020. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. Extract
  • GET 2020. Audio Interview: Covid-19 Vaccine Development. Extract
  • GET 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply. Extract
  • GET 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Extract
  • GET 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Extract
  • GET 2020. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Extract
  • GET 2020. How computational immunology changed the face of COVID-19 vaccine development. Extract
  • GET 2020. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Extract
  • GET 2020. COVID-19 vaccine development and a potential nanomaterial path forward. Extract
  • GET 2020. Controlling the SARS-CoV-2 spike glycoprotein conformation. Extract
  • GET 2020. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Extract
  • GET 2020. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Extract
  • GET 2020. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Extract
  • GET 2020. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Extract
  • GET 2020. Potently neutralizing and protective human antibodies against SARS-CoV-2. Extract
  • GET 2020. Coronavirus vaccines get a biotech boost. Extract
  • GET 2020. COVID-19 and tobacco - more questions than answers. Extract
  • GET 2020. Supplementation with vitamin D in the COVID-19 pandemic? Extract
  • GET 2020. Dietary recommendations during the COVID-19 pandemic. Extract
  • GET 2020. Efficacy of povidone-iodine to reduce viral load. Extract
  • GET 2020. Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review. Extract
  • GET 2020. The cardiovascular effects of treatment with hydroxychloroquine and azithromycin. Extract
  • GET 2020. Therapie mit Dexamethason bei Patienten mit COVID-19. Extract
  • GET 2020. DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19. Extract
  • GET 2020. Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Extract
  • GET 2020. Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones. Extract
  • GET 2020. Computer modelling of a potential agent against SARS-Cov-2 (COVID-19) protease. Extract
  • GET 2020. Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state. Extract
  • GET 2020. The effect of BCG vaccine in the era of COVID-19 pandemic. Extract
  • GET 2020. Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation? Extract
  • GET 2020. Is there really room for anti-rheumatic drugs in the treatment of COVID-19? Extract
  • GET 2020. An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Extract
  • GET 2020. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective. Extract
  • GET 2020. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? Extract
  • GET 2020. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development. Extract
  • GET 2020. Fish Oil and Covid-19 Thromboses. Extract
  • GET 2020. The SARS-CoV-2 N protein is a good component in a vaccine. Extract
  • GET 2020. Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns. Extract
  • GET 2020. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Extract
  • GET 2020. Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M(pro) via combinatorial molecular simulation calculations. Extract
  • GET 2020. Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis. Extract
  • GET 2020. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics. Extract
  • GET 2020. Anti-inflammatory Properties of Stingless Bee Honey May Reduce the Severity of Pulmonary Manifestations in COVID-19 Infections? Extract
  • GET 2020. Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations? Extract
  • GET 2020. Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate. Extract
  • GET 2020. Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll. Extract
  • GET 2020. Surfactant-based prophylaxis and therapy against COVID-19: A possibility. Extract
  • GET 2020. Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19. Extract
  • GET 2020. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients. Extract
  • GET 2020. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2. Extract
  • GET 2020. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. Extract
  • GET 2020. The Covid-19 Vaccine-Development Multiverse. Extract
  • GET 2020. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing. Extract
  • GET 2020. Immune-mediated approaches against COVID-19. Extract
  • GET 2020. The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report. Extract
  • GET 2020. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Extract
  • GET 2020. Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic. Extract
  • GET 2020. Immunologic Effects of Vitamin D on Human Health and Disease. Extract
  • GET 2020. Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options-A Critical Review of the Evidence. Extract
  • GET 2020. Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19. Extract
  • GET 2020. Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide. Extract
  • GET 2020. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Extract
  • GET 2020. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2. Extract
  • GET 2020. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment. Extract
  • GET 2020. Contribution of traditional Chinese medicine to the treatment of COVID-19. Extract
  • GET 2020. Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios. Extract
  • GET 2020. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Extract
  • GET 2020. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. Extract
  • GET 2020. COVID-19 and purinergic signaling: the need for investigation. Extract
  • GET 2020. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data. Extract
  • GET 2020. Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform. Extract
  • GET 2020. Worldwide inverse correlation between Bacille Calmette-Guerin immunization and COVID-19 morbidity and mortality. Extract
  • GET 2020. Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest. Extract
  • GET 2020. Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis. Extract
  • GET 2020. Pros and cons of corticosteroid therapy for COVID-19 patients. Extract
  • GET 2020. Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis. Extract
  • GET 2020. Use of remdesivir for patients with Covid-19: a review article. Extract
  • GET 2020. Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports. Extract
  • GET 2020. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2. Extract
  • GET 2020. Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development. Extract
  • GET 2020. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery. Extract
  • GET 2020. Cellular Therapy: Shafts of Light Emerging for COVID-19. Extract
  • GET 2020. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19. Extract
  • GET 2020. A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report. Extract
  • GET 2020. Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy. Extract
  • GET 2020. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19. Extract
  • GET 2020. COVID-19 Pandemic: Can Maintaining Optimal Zinc Balance Enhance Host Resistance? Extract
  • GET 2020. Immunomodulation for the management of corona virus disease (COVID-19). Extract
  • GET 2020. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials? Extract
  • GET 2020. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia. Extract
  • GET 2020. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma. Extract
  • GET 2020. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Extract
  • GET 2020. A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence-FAST Evidence. Extract
  • GET 2020. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Extract
  • GET 2020. The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data. Extract
  • GET 2020. Bacillus Calmette-Guerin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality. Extract
  • GET 2020. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Extract
  • GET 2020. Contingent assessment of the COVID-19 vaccine. Extract
  • GET 2020. Planning for COVID-19 vaccines safety surveillance. Extract
  • GET 2020. Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development. Extract
  • GET 2020. Significantly Improved COVID-19 Outcomes in Countries with Higher BCG Vaccination Coverage: A Multivariable Analysis. Extract
  • GET 2020. Images in Vascular Medicine: Peripheral artery thrombosis in critically ill patients with COVID-19. Extract
  • GET 2020. Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned. Extract
  • GET 2020. A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial. Extract
  • GET 2020. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis. Extract

head

  • GET ?. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience. Extract
  • GET ?. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence?. Extract
  • GET 2020. Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity??. Extract
  • GET 2020. ET-traps as a potential treatment for COVID-19. Extract
  • GET ?. Vitamin D Levels and COVID-19 Susceptibility: Is there any Correlation? Extract
  • GET ?. BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope? Extract
  • GET 2020. COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF). Extract
  • GET 2020. Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis. Extract
  • GET 2020. The immunomodulatory effects of exercise against COVID-19. Extract
  • GET 2020. Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate. Extract
  • GET 2020. Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll. Extract
  • GET 2020. Ibuprofen a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution. Extract
  • GET 2020. Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19. Extract
  • GET 2020. Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2. Extract
  • GET 2020. Rethinking interleukin-6 blockade for treatment of COVID-19. Extract
  • GET 2020. Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2. Extract
  • GET 2020. Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease. Extract
  • GET 2020. Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms. Extract
  • GET 2020. Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances. Extract
  • GET 2020. Statins may be a key therapeutic for Covid-19. Extract
  • GET ?. Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach. Extract
  • GET ?. Spectral domain optical coherence tomography?based prevalence of hydroxychloroquine maculopathy in Indian patients on hydroxychloroquine therapy: A utopia of underdiagnosis. Extract
  • GET 2020. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients. Extract
  • GET 2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure. Extract
  • GET ?. Immune-mediated approaches against COVID-19. Extract
  • GET ?. Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19. Extract
  • GET ?. Remdesivir investigational trials in COVID-19: a critical reappraisal. Extract
  • GET ?. Re. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Extract
  • GET 2020. COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution. Extract
  • GET ?. Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19. Extract
  • GET ?. Countermeasures to COVID-19: Are immunomodulators rational treatment options ? a critical review of the evidence. Extract
  • GET ?. Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action Clinical Development Synthesis at Scale and Outlook for Supply. Extract
  • GET ?. Development of a Large-Scale Cyanation Process Using Continuous Flow Chemistry En Route to the Synthesis of Remdesivir. Extract
  • GET ?. Potential influence of Nagella sativa (Black Cumin) in reinforcing immune system: a hope to decelerate the COVID-19 pandemic. Extract
  • GET ?. Contribution of traditional Chinese medicine to the treatment of COVID-19. Extract
  • GET ?. Phytochemicals as Antiviral Agents: Recent Updates. Extract
  • GET 2020. Topological Indices of Some Chemical Structures Applied for the Treatment of COVID-19 Patients. Extract
  • GET ?. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of COVID-19: Psychopharmacological Interactions and Neuropsychiatric Sequelae. Extract
  • GET ?. COVID-19 and purinergic signaling: the need for investigation. Extract
  • GET ?. Ethical rationale for better coordination of clinical research on COVID-19. Extract
  • GET ?. COVID-19: Famotidine Histamine Mast Cells and Mechanisms . Extract
  • GET ?. Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome. Extract
  • GET ?. An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein. Extract
  • GET ?. A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia. . Extract
  • GET ?. Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS . Extract
  • GET 2020. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Extract
  • GET 2020. Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases. Extract
  • GET 2020. Pros and cons of corticosteroid therapy for COVID-19 patients. Extract
  • GET ?. Réplica: Ivermectina en COVID-19. ¿Argumentum ad ignorantiam? Extract
  • GET 2020. Hypothèse en Asie : protection du Covid et vaccin anti-encéphalite ? Extract
  • GET 2020. 5-(Perylen-3-ylethynyl)uracil Derivatives Inhibit Reproduction of Respiratory Viruses. Extract
  • GET ?. In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors. Extract
  • GET ?. Structure-based drug designing and immunoinformatics approach for SARS-CoV-2. Extract
  • GET ?. Desperate Times Desperate Measures: The Case for RRx-001 in the Treatment of COVID-19. Extract
  • GET ?. Reply to Delirium sleep COVID-19 and melatonin . Extract
  • GET ?. Can HCQ Be Considered a ?Safe Weapon? for COVID-19 in the Indian Population? Extract
  • GET ?. Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage. Extract
  • GET ?. Ventricular Arrhythmia Risk Based on Ethnicity in COVID-19 Patients on Hydroxychloroquine and Azithromycin Combination: Viewpoint. Extract
  • GET ?. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19. Extract
  • GET 2020. Major Neurologic Adverse Drug Reactions Potential Drug?Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review. Extract
  • GET 2020. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population consider N-acetylcysteine as early therapeutic intervention. Extract
  • GET ?. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma. Extract
  • GET ?. Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report. Extract
  • GET ?. International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection. Extract
  • GET ?. A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence?FAST Evidence. Extract
  • GET 2020. Compressed fluids and phytochemical profiling tools to obtain and characterize antiviral and anti-inflammatory compounds from natural sources. Extract
  • GET 2020. Bacillus Calmette?Guérin vaccine antimalarial age and gender relation to COVID-19 spread and mortality. Extract
  • GET ?. A review on Promising vaccine development progress for COVID-19 disease. Extract
  • GET ?. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Extract
  • GET 2020. Hydroxychloroquine retinal toxicity: The bull s eye in the human eye. Extract
  • GET 2020. Exploration on the feasibility of moxibustion in prevention and treatment of COVID-19 from the perspective of modern medical mechanism. Extract
  • GET ?. Homeopathy combat against coronavirus disease (Covid-19). Extract

head

  • GET 2020. Review of: ?Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010 DOI:10.1016/j.ijantimicag.2020.105949. Extract
  • GET 2020. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? Extract
  • GET 2020. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines. Extract
  • GET 2020. Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes influenza and other viral infections. Extract
  • GET 2020. A consensus guideline of herbal medicine for coronavirus disease 2019. Extract
  • GET 2020. Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines. Extract
  • GET 2020. Allium fistulosum congee as a home remedy to ward off the corona virus at an early stage. Extract
  • GET 2020. COVID-19 ? Where should we go now? Extract
  • GET 2020. The potential benefits of Chinese integrative medicine for pregnancy women during the COVID-19 pandemic. Extract
  • GET 2020. The evaluation of online course of Traditional Chinese Medicine for MBBS international students during the COVID-19 epidemic period. Extract
  • GET ?. COVID?19: A review of therapeutics under investigation. Extract
  • GET 2020. Plasma Therapies and Parabiosis in the COVID-19 Era. Extract
  • GET ?. The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial supporting research about the antiviral properties of seaweed polysaccharides seem to go unrecognized by the pharmaceutical community in these desperate times? Extract
  • GET ?. Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients. Extract
  • GET ?. Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report. Extract
  • GET 2020. Leucoefdin a potential inhibitor against SARS CoV-2 Mpro. Extract
  • GET 2020. Drug targets for COVID-19 therapeutics: Ongoing global efforts. Extract
  • GET ?. Achieving Effective Informed Oversight by DMCs in COVID Clinical Trials. Extract
  • GET ?. Are statins safe in patients with COVID-19? Extract
  • GET 2020. Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19. Extract
  • GET ?. Drug repurposing using computational methods to identify therapeutic options for COVID-19. Extract
  • GET ?. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome. Extract
  • GET 2020. Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19. Extract
  • GET ?. An overview of the safety clinical application and antiviral research of the COVID-19 therapeutics. Extract
  • GET 2020. Increasing Immunity to Fight against Novel COVID-19: Noninvasive Public Health Approach. Extract
  • GET ?. Hydroxychloroquine treatment in COVID?19: a descriptive observational analysis of 30 cases from a single center in Wuhan China. Extract
  • GET 2020. Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine. Extract
  • GET 2020. Inhibition of SARS-CoV-2 main protease 3CLpro by means of ?-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking. Extract
  • GET 2020. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. Extract
  • GET 2020. Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis physicochemical quantum chemical modeling and molecular docking analysis. Extract
  • GET 2020. Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies. Extract
  • GET ?. Is Vitamin D One of the Key Elements in COVID-19 Days? Extract
  • GET ?. Nutritional Considerations in Frail Older Patients with COVID-19. Extract
  • GET ?. Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes. Extract
  • GET 2020. Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective. Extract
  • GET 2020. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? Extract
  • GET 2020. Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19. Extract
  • GET 2020. Minimum costs to manufacture new treatments for COVID-19. Extract
  • GET 2020. A review of the safety of favipiravir ? a potential treatment in the COVID-19 pandemic? Extract
  • GET 2020. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections 8?11 March 2020 Boston USA. Extract
  • GET 2020. Acute Cor Pulmonale in COVID-19-Related ARDS: Improvement With Almitrine Infusion. Extract
  • GET ?. Hydroxychloroquine-associated Hypoglycemia in Hemodialysis Patients with COVID-19. Extract
  • GET ?. Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD? Extract
  • GET 2020. Probiotics and COVID-19. Extract
  • GET 2020. Probiotics and COVID-19 ? Authors reply. Extract
  • GET 2020. Probiotics and COVID-19. Extract
  • GET 2020. Development of potential COVID-19 vaccines continues to accelerate. Extract
  • GET ?. Iloprost for COVID-19-related vasculopathy. Extract
  • GET 2020. Anakinra for patients with COVID-19. Extract
  • GET 2020. Anakinra for patients with COVID-19. Extract
  • GET 2020. Anakinra for patients with COVID-19. Extract
  • GET 2020. Anakinra for patients with COVID-19 ? Authors reply. Extract
  • GET 2020. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Extract
  • GET 2020. Can tocilizumab calm the cytokine storm of COVID-19? Extract
  • GET 2020. Canakinumab in a subgroup of patients with COVID-19. Extract
  • GET 2020. Anakinra for severe forms of COVID-19: a cohort study. Extract
  • GET 2020. Anakinra in COVID-19: important considerations for clinical trials. Extract
  • GET 2020. The immunology of COVID-19: is immune modulation an option for treatment? Extract
  • GET 2020. Calming the Cytokine Storm in Pneumonia by Biomimetic Nanoparticles. Extract
  • GET 2020. Calming Cytokine Storm in Pneumonia by Targeted Delivery of TPCA-1 Using Platelet-Derived Extracellular Vesicles. Extract
  • GET 2020. Clinical Trial End Points in Severe COVID-19. Extract
  • GET 2020. Vitamin D Supplementation During the COVID-19 Pandemic. Extract
  • GET 2020. Famotidine Against SARS-CoV2: A Hope or Hype? Extract
  • GET 2020. Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection. Extract
  • GET ?. Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials. Extract
  • GET ?. Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Extract
  • GET ?. Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia. Extract
  • GET ?. Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir. Extract
  • GET ?. Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2. Extract
  • GET ?. Agentes terapéuticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relación con la mortalidad. Extract
  • GET ?. Abordaje terapéutico del SARS-CoV-2 (COVID-19) mediante células mesenquimales de médula ósea alogénica expandidas. Conceptos a propósito de un primer caso en España. Extract
  • GET ?. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection?. Extract
  • GET 2020. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Extract
  • GET 2020. The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection. Extract
  • GET 2020. Immunological fortification at our barrier organs: Protecting us as we age. Extract
  • GET 2015. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Extract
  • GET 2020. Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation? Extract
  • GET 2020. HCQ induced QT prolongation- Primum non nocere. Extract
  • GET 2020. That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19. Extract
  • GET 2020. Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis. Extract
  • GET 2020. Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung. Extract
  • GET 2020. Emerging pharmacological therapies for ARDS: COVID-19 and beyond. Extract
  • GET 2020. Therapeutic and prophylactic potential of anti-microbial peptides against coronaviruses. Extract
  • GET 2020. Current Status of COVID-19 Therapies and Drug Repositioning Applications. Extract
  • GET 2020. Retrospective Analysis of Dermatological Adverse Events Associated with Hydroxychloroquine Reported to the United States Food and Drug Administration. Extract
  • GET 2020. Role of phototherapy in the era of biologics. Extract
  • GET 2020. The roles of PPARgamma and its agonists in autoimmune diseases: A comprehensive review. Extract
  • GET 2020. Ayurvedic clinical profile of COVID-19 - A preliminary report. Extract
  • GET 2020. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations. Extract
  • GET 2020. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. Extract
  • GET 2020. Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective. Extract
  • GET 2008. Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors. Extract
  • GET 2020. First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA. Extract
  • GET 2020. Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence. Extract
  • GET 2005. SARS-CoV protease inhibitors design using virtual screening method from natural products libraries. Extract
  • GET 2020. Efficacy and safety of hydroxychloroquine as add-on therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs. Extract
  • GET 2020. The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection. Extract
  • GET 2020. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. Extract
  • GET 2018. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review. Extract
  • GET 2020. QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin. Extract
  • GET 2008. Metabolite identification of arbidol in human urine by the study of CID fragmentation pathways using HPLC coupled with ion trap mass spectrometry. Extract
  • GET 2020. How materials can beat a virus. Extract
  • GET 2020. Materials Science in the time of Coronavirus. Extract
  • GET 2020. Acute kidney injury is associated with the mortality of coronavirus disease 2019. Extract
  • GET 2020. Tocilizumab in patients with severe COVID-19: A single-center observational analysis. Extract
  • GET 2020. Whole Genome Analysis and Targeted Drug Discovery Using Computational Methods and High Throughput Screening Tools for Emerged Novel Coronavirus (2019-nCoV). Extract
  • GET 2020. Drug repositioning: a brief overview. Extract
  • GET 2020. SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3. Extract
  • GET 2020. A case of cytokine hemofiltration and extracorporeal life support as treatment of coronavirus disease 2019 (COVID-19) respiratory failure. Extract
  • GET 2020. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. Extract
  • GET 2020. Addressing the "What do we have to lose? Just give the drug" rationale: making the case for clinical trials and against off-label use in COVID-19. Extract
  • GET 2020. "Right-to-Try" experimental drugs: an overview. Extract
  • GET 2020. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development. Extract
  • GET 2020. Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages. Extract
  • GET 2008. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. Extract
  • GET 2020. Alveolar lipids in pulmonary disease. A review. Extract
  • GET 2020. Surfactant-based prophylaxis and therapy against COVID-19: A possibility. Extract
  • GET 2020. Del empirismo a la evidencia cientifica en el tratamiento con antiviricos en los casos graves de infeccion por coronavirus en tiempos de epidemia. Extract
  • GET 2020. Coronavirus vaccine-associated lung immunopathology-what is the significance? Extract
  • GET 2020. The alpha7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Extract
  • GET 2020. Preparing for Pandemics: RNA Vaccines at the Forefront. Extract
  • GET 2020. Antiviral Effects of Plant-Derived Essential Oils and Their Components: An Updated Review. Extract
  • GET 2020. Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight. Extract
  • GET 2020. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses. Extract
  • GET 2020. Remdesivir - An Important First Step. Extract
  • GET 2020. Type I and type III interferon in opposition? Extract
  • GET 2020. Dexamethasone to the rescue. Extract
  • GET 2020. Drug repurposing in cardiology. Extract
  • GET 2020. The 'president's drug'. Extract
  • GET 2020. An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation. Extract
  • GET 2020. Nicotinic acetylcholine receptors regulate clustering, fusion and acidification of the rat brain synaptic vesicles. Extract
  • GET 2020. Better patient identification could help fight the coronavirus. Extract
  • GET 2020. Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic. Extract
  • GET 2020. New international guidance on quality, safety and efficacy of DNA vaccines. Extract
  • GET 2020. WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019. Extract
  • GET 2020. Is a vitamin D fortification strategy needed? Extract
  • GET 2020. Vitamin D and Immunity in Infants and Children. Extract
  • GET 2020. A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis. Extract
  • GET 2020. Key Vitamin D Target Genes with Functions in the Immune System. Extract
  • GET 2020. Effects of an Omega-3 and Vitamin D Supplement on Fatty Acids and Vitamin D Serum Levels in Double-Blinded, Randomized, Controlled Trials in Healthy and Crohn's Disease Populations. Extract
  • GET 2020. The Role of Selenium in Health and Disease: Emerging and Recurring Trends. Extract
  • GET 2020. Hydroxychloroquine-induced Stevens-Johnson syndrome in COVID-19: a rare case report. Extract
  • GET 2020. Covering coronavirus-emerging tools for the fight against the common enemy. Extract
  • GET 2020. Vaccines for COVID-19: The current state of play. Extract
  • GET 2020. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Extract
  • GET 2020. Global research on artemisinin and its derivatives: Perspectives from patents. Extract
  • GET 2020. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2. Extract
  • GET 2020. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment. Extract
  • GET 2020. Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus. Extract
  • GET 2020. News Feature: To counter the pandemic, clinicians bank on repurposed drugs. Extract
  • GET 2007. Crystallographic studies of the complexes of antiviral protein griffithsin with glucose and N-acetylglucosamine. Extract
  • GET 2007. Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Extract
  • GET 2020. Possible beneficial role of throat gargling in the coronavirus disease pandemic. Extract
  • GET 2020. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Extract
  • GET 2020. Ivermectina en COVID-19. inverted question markArgumentum ad ignorantiam? Extract
  • GET 2020. Electrocardiographic/QT interval monitoring with a portable device in hospitalized patients with COVID-19: a protocol proposal. Extract
  • GET 2020. Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have! Extract
  • GET 2020. The presence of heart disease worsens prognosis in patients with COVID-19. Extract
  • GET 2020. Recommandations EMA sur l'usage compassionnel du remdesivir. Extract
  • GET 2020. Hochdosiertes Chloroquin bei COVID-19 gefahrlich. Extract
  • GET 2020. A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques. Extract
  • GET 2020. Ginkgolic acid inhibits fusion of enveloped viruses. Extract
  • GET 2020. Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury. Extract
  • GET 2020. How to "Detronize" Virus in Crown - Questions to Current Stem Cell Therapies. Extract
  • GET 2020. An aurora of natural products-based drug discovery is coming. Extract
  • GET 2020. Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents. Extract
  • GET 2020. Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19. Extract
  • GET 2020. Immunomodulation for the management of corona virus disease (COVID-19). Extract
  • GET 2020. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials? Extract
  • GET 2020. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia. Extract
  • GET 2020. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption. Extract
  • GET 2020. The true historical origin of convalescent plasma therapy. Extract
  • GET 2020. Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products. Extract
  • GET 2020. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light. Extract
  • GET 2020. Convalescent plasma - this is no time for competition. Extract
  • GET 2014. Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates. Extract
  • GET 2020. Innovative highlights of clinical drug trial design. Extract
  • GET 2020. Traditional Chinese Herbal Medication for corona-virus 2019. Extract
  • GET 2020. Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome? Extract
  • GET 2020. Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates. Extract
  • GET 2020. Vacunas contra el coronavirus. Extract
  • GET 2020. Chloroquine/Hydroxychloroquine Overdose. Extract
  • GET 2020. Pivotal role of convalescent plasma in managing emerging infectious diseases. Extract
  • GET 2003. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. Extract

head

  • GET ?. Artemisia and COVID-19. Extract
  • GET ?. Vitamin D and COVID-19. Extract
  • GET ?. Anti-SARS-CoV-2 hyperimmune immunoglobulins an urgent strategic choice. Extract
  • GET 2020. Isolation and characterization of an exopolymer produced by Bacillus licheniformis: In vitro antiviral activity against enveloped viruses. Extract
  • GET 2020. A review for natural polysaccharides with anti-pulmonary fibrosis properties which may benefit to patients infected by 2019-nCoV. Extract
  • GET 2020. Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4+ T cell apoptosis. Extract
  • GET ?. Development of an Inactivated Vaccine Candidate BBIBP-CorV with Potent Protection against SARS-CoV-2. Extract
  • GET 2020. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice. Extract
  • GET 2020. Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity. Extract
  • GET 2020. Efficient degradation of chloroquine drug by electro-Fenton oxidation: Effects of operating conditions and degradation mechanism. Extract
  • GET 2020. SYSTEMATIC REVIEW OF THE ONGOING CLINICAL TRIALS EVALUATING THE DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO MANAGE THE RESPIRATORY INFECTION CAUSED BY 2019 NOVEL CORONAVIRUS (2019-NCOV). Extract
  • GET ?. Traditional Chinese medicine played a crucial role in battling COVID-19. Extract
  • GET ?. Carry forward advantages of traditional medicines in prevention and control of outbreak of COVID-19 pandemic. Extract
  • GET 2020. Electron beam irradiation on novel coronavirus (COVID-19): A Monte?Carlo simulationProject supported by the National Natural Science Foundation of China (Grant No. 61901360). Extract
  • GET ?. Process integration for emerging challenges: optimal allocation of antivirals under resource constraints. Extract
  • GET ?. Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-Cov-2 in pemphigus cases???. Extract
  • GET 2020. Intestinal microbiome transfer a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to ?COVID-19: Immunology and treatment options? Felsenstein Herbert McNamara et al. 2020?. Extract
  • GET ?. Targeting complement in severe Coronavirus disease 2019 to address microthrombosis. Extract
  • GET ?. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma. Extract
  • GET ?. Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib. Extract
  • GET 2020. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis. Extract
  • GET 2020. Foodomics and COVID-19. Extract
  • GET 2020. Home medical nutrition during SARS-CoV-2 pandemic ? A position paper. Extract
  • GET 2020. New thinking in the treatment of 2019 novel coronavirus pneumonia. Extract
  • GET 2020. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19. Extract
  • GET 2020. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach. Extract
  • GET 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans. Extract
  • GET 2020. Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study. Extract
  • GET 2020. The Combination of Tocilizumab and Methylprednisolone Along With Initial Lung Recruitment Strategy in Coronavirus Disease 2019 Patients Requiring Mechanical Ventilation: A Series of 21 Consecutive Cases. Extract
  • GET 2020. Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019. Extract
  • GET 2020. Corticosteroid Administration Is Associated With Improved Outcome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2-Related Acute Respiratory Distress Syndrome. Extract
  • GET ?. Can Vitamins as Epigenetic Modifiers Enhance Immunity in COVID-19 Patients with Non-communicable Disease? Extract
  • GET ?. COVID-19 Drug Treatment in China. Extract
  • GET ?. Are we fully exploiting type I Interferons in today s fight against COVID-19 pandemic? Extract
  • GET ?. Hydroxychloroquine for COVID?19: Myths vs Facts. Extract
  • GET 2020. Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19). Extract
  • GET ?. Traditional Chinese Medicine and Clinical Pharmacology. Extract
  • GET ?. Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis. Extract
  • GET ?. Within a large healthcare system the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy. Extract
  • GET ?. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. Extract
  • GET 2020. Subcutaneous tocilizumab treatment in patients with severe COVID-19?related cytokine release syndrome: An observational cohort study. Extract
  • GET 2020. Endpoints used in phase III randomized controlled trials of treatment options for COVID-19. Extract
  • GET 2020. Serosurveys and convalescent plasma in COVID-19. Extract
  • GET ?. The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol. Extract
  • GET ?. Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome. Extract
  • GET 2020. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Extract
  • GET 2020. Special issues raised by evolving areas of clinical research. Extract
  • GET 2020. Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19. Extract
  • GET ?. COVID-19 treatment with lopinavir?ritonavir resulting in sick sinus syndrome: a case report. Extract
  • GET 2020. Severe COVID-19: NLRP3 Inflammasome Dysregulated. Extract
  • GET 2020. Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy? Extract
  • GET 2020. Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy. Extract
  • GET 2020. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? Extract
  • GET ?. N-acetylcysteine as a potential treatment for novel coronavirus disease 2019. Extract
  • GET ?. Better preventing and mitigating the effects of Covid-19. Extract
  • GET ?. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Extract
  • GET ?. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise. Extract
  • GET ?. Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors. Extract
  • GET 2020. mTOR inhibition and p53 activation microRNAs: The possible therapy against pandemic COVID-19. Extract
  • GET ?. Known drugs and small molecules in the battle for COVID-19 treatment. Extract
  • GET ?. Chloroquine kills hair cells in zebrafish lateral line and murine cochlear cultures: Implications for ototoxicity. Extract
  • GET ?. QT Interval and Arrhythmic Safety of Hydroxychloroquine Monotherapy in Coronavirus Disease 2019. Extract
  • GET 2020. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation. Extract
  • GET 2020. Intermittent fasting a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction autophagy and immune response. Extract
  • GET ?. Obesity and COVID-19: A Fatal Alliance. Extract
  • GET ?. Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic. Extract
  • GET ?. Does the Bacillus Calmette?Guérin vaccine provide protection from COVID-19? Extract
  • GET ?. Role of poly (ADP) ribose polymerase-1 inhibition by nicotinamide as a possible additive treatment to modulate host immune response and prevention of cytokine storm in COVID-19. Extract
  • GET ?. Modified Bhramari Pranayama in Covid 19 Infection. Extract
  • GET ?. Letter to the Editor: Acharya Prafulla Chandra Ray Hydroxychloroquine and COVID-19. Extract
  • GET ?. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ?lasso? for the multi-faced virus. Extract
  • GET 2020. Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15. Extract

head

  • GET 2020. Remdesivir: Various toxicities: 4 case reports. Extract
  • GET 2020. Multiple drugs interaction: Reduction in drug level and QTc prolongation following off label use: 2 case reports. Extract
  • GET 2020. Tocilizumab: Neutropenia: case report. Extract
  • GET 2020. Hydroxychloroquine: Acute haemolysis that lead to acute renal failure: case report. Extract
  • GET 2020. Multiple drugs: Bradycardia atrioventricular block and off-label use: case report. Extract
  • GET 2020. The use of corticosteroids for COVID-19 infection. Extract
  • GET 2020. Azithromycin/hydroxychloroquine/propofol: Hypoglycaemia and cardiotoxicities following off label use: 2 case reports. Extract
  • GET 2020. Hydroxychloroquine: Corrected QT interval prolongation first degree atrioventricular block and left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia: 3 case reports. Extract
  • GET 2020. Etanercept/methotrexate: COVID-19: case report. Extract
  • GET 2020. Hydroxychloroquine: QTc prolongation following off-label-use: case report. Extract
  • GET 2020. Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report. Extract
  • GET 2020. New potential interaction with emergency COVID-19 medicine remdesivir. Extract
  • GET 2020. Bréve : Chloroquine OTC : danger ! Extract
  • GET 2020. COVID-19: Wirksamkeit integrativer Medizin? Extract
  • GET ?. Risiken und Chancen von Immuntherapien in Zeiten der Coronavirus-2019-Pandemie. Extract
  • GET ?. Los antimaláricos (cloroquina e hidroxicloroquina) en la pandemia COVID-19. Extract
  • GET 2020. Emerging Treatment and Prevention Strategies against COVID-19: A Brief Update. Extract
  • GET 2020. Exploring COVID-19 Therapies: An Extraordinary Global Challenge. Extract
  • GET 2020. Azithromycin ? An Antibiotic to Fight COVID-19? Extract
  • GET 2020. Hydroxychloroquine ? An Antimalarial to Fight COVID-19? Extract
  • GET 2020. ?-Ketoamide Inhibitors of SARS-CoV-2 Main Protease. Extract
  • GET ?. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Extract
  • GET 2020. Abemaciclib/fulvestrant: Leucopenia and Covid-19: case report. Extract
  • GET 2020. Prednisone: Coronavirus disease 2019: case report. Extract
  • GET 2020. Evaluation of potential therapies for COVID-19 global pandemic. Extract
  • GET 2020. Demand for potentially hazardous COVID-19 treatments. Extract
  • GET 2020. Hydroxychloroquine-associated QT interval prolongation. Extract
  • GET 2020. Current evidence for directed and supportive investigational therapies against COVID-19. Extract
  • GET ?. COVID-19 ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury. Extract
  • GET ?. Translation: Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7): National Health Commission National Administration of Traditional Chinese Medicine. Extract
  • GET ?. CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection. Extract
  • GET ?. Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment. Extract
  • GET ?. Exploiting Existing Molecular Scaffolds for Long-Term COVID Treatment. Extract
  • GET 2020. Recommender Systems in Antiviral Drug Discovery. Extract
  • GET ?. The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19. Extract
  • GET ?. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Extract
  • GET ?. Bioactive natural compounds against human coronaviruses: a review and perspective. Extract
  • GET ?. Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight. Extract
  • GET ?. Analysis on herbal medicines utilized for treatment of COVID-19. Extract
  • GET ?. Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment. Extract
  • GET ?. Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model. Extract
  • GET ?. Chinese medicine diagnosis and treatment for COVID-2019: Is China ready for implementing a national guideline? Extract
  • GET ?. Addressing COVID?19 Drug Development with Artificial Intelligence. Extract
  • GET ?. Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History. Extract
  • GET ?. Covert COVID-19: Cone Beam Computed Tomography Lung Changes in an Asymptomatic Patient Receiving Radiation Therapy. Extract
  • GET 2020. Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae. Extract
  • GET 2020. Pharmaceutical care of chloroquine phosphate in elderly patients with coronavirus pneumonia (COVID?19). Extract
  • GET ?. The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis. Extract
  • GET ?. Traditional chinese medicine and COVID-19: should emergency practitioners use it? Extract
  • GET ?. Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review. Extract
  • GET ?. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center. Extract
  • GET ?. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. Extract
  • GET ?. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature. Extract
  • GET 2020. Reply to Jakovac: ?COVID-19 and vitamin D?Is there a link and an opportunity for intervention??. Extract
  • GET ?. Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome?. Extract
  • GET 2020. The use of dexamethasone in the treatment of COVID-19. Extract
  • GET 2020. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Extract
  • GET ?. Immunoglobulin fragment F(ab?)2 against RBD potently neutralizes SARS-CoV-2 in vitro. Extract
  • GET 2020. Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection. Extract
  • GET ?. Hydroxychloroquine and Potential Drug Interactions in Older Adults. Extract
  • GET ?. Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19. Extract
  • GET ?. Response to: Amantadine Treatment for People with COVID-19. Extract
  • GET ?. Recent insights for the emerging COVID-19: drug discovery therapeutic options and vaccine development. Extract
  • GET ?. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand. Extract
  • GET 2020. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Extract
  • GET 2020. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a. Extract
  • GET 2020. The SARS-CoV-2 main protease as drug target. Extract
  • GET ?. Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? Extract
  • GET ?. Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment. Extract
  • GET ?. Artemisia et COVID-19. Extract
  • GET ?. Vaccinating against COVID-19: The quest for the Grail? Extract
  • GET ?. Thermal cures and COVID-19. Extract

head

  • GET 2020. Coronavirus vaccines. Extract
  • GET 2020. Hydroxychloroquine: QTc prolongation: case report. Extract
  • GET 2020. Methylprednisolone/prednisone: Accelerated viral replication following an off-label treatment: case report. Extract
  • GET 2020. Antibacterials/isavuconazole/voriconazole: Lack of efficacy: case report. Extract
  • GET 2020. Multiklonale Antikörper als Ersatz für Zweitantikörper aus Seren. Extract
  • GET 2020. Rekombinante vollständig humane Antikörper zur Behandlung akuter COVID-19. Extract
  • GET 2020. Azaphenantherene derivatives as inhibitor of SARS CoV-2 Mpro: Synthesis physicochemical quantum chemical and molecular docking analysis. Extract
  • GET 2020. COVID-19 und evidenzbasierte Medizin. Extract
  • GET 2020. Remdesivir wohl wirksam bei COVID-19. Extract
  • GET 2020. Lopinavir-Ritonavir-Kombination nicht wirksam. Extract
  • GET 2020. Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report. Extract
  • GET 2020. Methylprednisolone: Decrease in T cell count following off label use: case report. Extract
  • GET 2020. Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019. Extract
  • GET ?. Cholesterol-modifying drugs in COVID-19. Extract
  • GET 2020. Extraction, Characterization, and Anticoagulant Activity of a Sulfated Polysaccharide from Bursatella leachii Viscera. Extract
  • GET 2020. Targeting drug delivery in the vascular system: Focus on endothelium. Extract
  • GET 2020. Comments on: The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Extract
  • GET 2020. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic? Extract
  • GET 2020. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19. Extract
  • GET 2020. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions. Extract
  • GET 2020. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? Extract
  • GET 2020. Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk? Extract
  • GET 2020. A severe refractory COVID-19 patient responding to convalescent plasma; A case series. Extract
  • GET 2020. Does androgen deprivation therapy protect against severe complications from COVID-19? Extract
  • GET 2020. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions. Extract
  • GET 2020. The Application of a Reduced Dye Used in Orthopedics as a Novel Treatment against Coronavirus (COVID-19): A Suggested Therapeutic Protocol. Extract
  • GET 2020. Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19? Extract
  • GET 2020. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development. Extract
  • GET 2020. Clinical implications of nicotine as an antimicrobial agent and immune modulator. Extract
  • GET 2020. Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice. Extract
  • GET 2020. Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity. Extract
  • GET 2020. Antiviral Action of Tryptanthrin Isolated from Strobilanthes cusia Leaf against Human Coronavirus NL63. Extract
  • GET 2020. COVID19 inhibitors: A prospective therapeutics. Extract
  • GET 2012. Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Extract
  • GET 2020. Built-in RNA-mediated chaperone (chaperna) for antigen folding tailored to immunized hosts. Extract
  • GET 2019. Synthetic biology for bioengineering virus-like particle vaccines. Extract
  • GET 2015. Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology. Extract
  • GET 2010. Generating stable Chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development. Extract
  • GET 2005. Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic. Extract
  • GET 2020. Network pharmacology to dissect the mechanisms of Yinlai Decoction for pneumonia. Extract
  • GET 2020. Food is medicine: actions to integrate food and nutrition into healthcare. Extract
  • GET 2020. Hydrogen peroxide mouthwash. Extract
  • GET 2020. New video will promote silver diamine fluoride to children. Extract
  • GET 2020. Chlorhexidine has an antiviral effect against viruses. Extract
  • GET 2020. Virucidal activity. Extract
  • GET 2020. Povidone iodine gargle and mouthwash. Extract
  • GET 2020. Extensive hard palate hyperpigmentation associated with chloroquine use. Extract
  • GET 2020. Ivermectin: potential candidate for the treatment of Covid 19. Extract
  • GET 2020. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Extract
  • GET 2020. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Extract
  • GET 2020. Enhancing the Antiviral Efficacy of RNA-Dependent RNA Polymerase Inhibition by Combination with Modulators of Pyrimidine Metabolism. Extract
  • GET 2020. BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment. Extract
  • GET 2020. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Extract
  • GET 2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Extract
  • GET 2020. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19. Extract
  • GET 2006. Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141. Extract
  • GET 2013. Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications. Extract
  • GET 2020. Impact of Small-N Studies During a Pandemic. Extract
  • GET 2020. Adjunctive Therapies in ARDS: The Disconnect Between Clinical Trials and Clinical Practice. Extract
  • GET 2020. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking. Extract
  • GET 2020. Remdesivir - A giant step, or a tiptoe? Extract
  • GET 2020. Tuberculosis sepsis after tocilizumab treatment. Extract
  • GET 2020. COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use. Extract
  • GET 2020. Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial. Extract
  • GET 2020. What Do We Know About Remdesivir Drug Interactions? Extract
  • GET 2020. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors. Extract
  • GET 2020. Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease. Extract
  • GET 2020. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia. Extract
  • GET 2020. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis. Extract
  • GET 2020. Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019. Extract
  • GET 2020. Lithium Toxicity in Two Coronavirus Disease 2019 (COVID-19) Patients. Extract
  • GET 2020. Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review. Extract
  • GET 2020. Packed Red Blood Cell Transfusion as a Potential Treatment Option in COVID-19 Patients With Hypoxemic Respiratory Failure: A Case Report. Extract
  • GET 2020. Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases. Extract
  • GET 2020. Docking approaches for modeling multi-molecular assemblies. Extract
  • GET 2020. Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview. Extract
  • GET 2020. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy. Extract
  • GET 2020. A critical evaluation of glucocorticoids in the management of severe COVID-19. Extract
  • GET 2020. The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19. Extract
  • GET 2020. Repurposing therapeutic agents and herbal medicines to defeat viral nemesis. Extract
  • GET 2020. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments. Extract
  • GET 2020. Can vitamins and/or supplements provide hope against coronavirus? Extract
  • GET 2019. Evaluation of safety, humoral immune response and faecal shedding in horses inoculated with a modified-live bovine coronavirus vaccination. Extract
  • GET 2020. Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine? Extract
  • GET 2020. Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase(R). Extract
  • GET 2020. Waste in COVID-19 clinical trials conducted in western Europe. Extract
  • GET 2020. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal. Extract
  • GET 2020. Natural and nature-inspired stilbenoids as antiviral agents. Extract
  • GET 2020. Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon lambda In Vitro And In Mice. Extract
  • GET 2020. Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)? Extract
  • GET 2020. Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria. Extract
  • GET 2020. Hydroxychloroquine hitting the headlines-retinal considerations. Extract
  • GET 2020. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Extract
  • GET 2020. Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2. Extract
  • GET 2020. Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics? Extract
  • GET 2020. Targeting the NLRP3 Inflammasome in Severe COVID-19. Extract
  • GET 2020. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies. Extract
  • GET 2020. Three Decades of Interferon-beta in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? Extract
  • GET 2020. Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients. Extract
  • GET 2020. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Extract
  • GET 2020. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids. Extract
  • GET 2020. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy. Extract
  • GET 2020. Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs. Extract
  • GET 2020. Quantitative Proteomic Analysis Reveals Antiviral and Anti-inflammatory Effects of Puerarin in Piglets Infected With Porcine Epidemic Diarrhea Virus. Extract
  • GET 2020. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China. Extract
  • GET 2020. Biocides and Novel Antimicrobial Agents for the Mitigation of Coronaviruses. Extract
  • GET 2020. Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19. Extract
  • GET 2020. A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic. Extract
  • GET 2020. Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare. Extract
  • GET 2020. The Potential Beneficial Effect of EPA and DHA Supplementation Managing Cytokine Storm in Coronavirus Disease. Extract
  • GET 2020. Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection. Extract
  • GET 2020. Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases. Extract
  • GET 2020. The Emerging Role of Convalescent Plasma in the Treatment of COVID-19. Extract
  • GET 2020. The value of targeting recombination as a strategy against coronavirus diseases. Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge